The Evaluation of Patients with Severe COVID-19 Pneumonia Who are Recieving Favipiravir Treatment

The Evaluation of Patients with Severe COVID-19 Pneumonia Who are Recieving Favipiravir Treatment

Introduction: There is no known specific treatment for Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Our retrospective study evaluates the effectiveness of steroid treatment and the factors affecting treatment in patients with severe Coronavirus disease-2019 (COVID-19) pneumonia that...

Full description

Bibliographic Details
Main Authors: Servet ÖZTÜRK, Onur ÇOLAK, Semra KAVAS, Derya ÖZTÜRK ENGİN, Serap DİKTAŞ TAHTASAKAL, Dilek ERDOĞAN ARI, Öznur DEMİROLUK, Berna ÖZDEMİR, Büşra Meral ÇETİNKAYA, Merve KAÇAR EKER, İrem Asena DOĞAN, Haluk VAHABOĞLU, Canan AĞALAR
Format: Article
Language:Turkish
Published: Galenos Yayinevi 2021-12-01
Series:Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:
covid-19
sars-cov-2
favipiravir
steroid
Online Access:http://mjima.org/abstract.php?id=238

Internet

http://mjima.org/abstract.php?id=238

Similar Items